ESC 365 - HFpEF management: state of the art SGLT2 inhibitors.

ESC Premium Access

HFpEF management: state of the art SGLT2 inhibitors.

Session: How-To manage HFpEF: state of the art in 2021

Topic: Chronic Heart Failure

Speaker: Professor R. De Boer (Rotterdam, NL)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Professor Rudolf De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

60 presentations

8 followers

4 more presentations in this session

HFpEF management: state of the art neurohumoral modulation.

Speaker: Professor S. Solomon (Boston, US)

HFpEF management: state of the art novel devices.

Speaker: Professor D. Kaye (Melbourne, AU)

How-To manage HFpEF: state of the art in 2021 – discussion.

How-To manage HFpEF: state of the art in 2021 - Chat Moderator.

Access the full session

How-To manage HFpEF: state of the art in 2021

Speakers: Professor R. De Boer, Professor S. Solomon, Professor D. Kaye

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources